PMID- 19174182 OWN - NLM STAT- MEDLINE DCOM- 20090617 LR - 20131121 IS - 0306-4522 (Print) IS - 0306-4522 (Linking) VI - 159 IP - 2 DP - 2009 Mar 17 TI - Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat. PG - 850-61 LID - 10.1016/j.neuroscience.2008.12.051 [doi] AB - Several studies have shown that the 5-hydroxytryptamine (serotonin, 5-HT) system is severely affected after degeneration of nigrostriatal dopaminergic neurons. In the present study, we examined the changes in the firing rate and firing pattern of the dorsal and median raphe nuclei (DRN and MRN) 5-HT neurons, and the effect of the selective 5-HT(1A) receptor agonist (R)-(+)-8-hydroxy-2-(dipropylamino)tetralin hydrobromide (8-OH-DPAT) and antagonist (N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-2-pyridylcyclohexane carboxamide maleate salt (WAY-100635) on the neuronal firing in rats with 6-hydroxydopamine (6-OHDA) lesions of the substantia nigra pars compacta by using extracellular recording. The unilateral lesion of the nigrostriatal pathway significantly increased the mean firing rate of DRN and MRN 5-HT neurons compared with normal rats, and the firing pattern of these neurons also changed significantly towards a more bursty one. The lower dose of 8-OH-DPAT, 4 microg/kg (cumulative doses, i.v.), completely inhibited the firing activity of all DRN and MRN 5-HT neurons examined in normal and sham rats. In contrast to normal and sham rats, only the higher doses of 8-OH-DPAT, 128 and 64 microg/kg, completely inhibited the firing rate of DRN and MRN 5-HT neurons in 6-OHDA-lesioned rats, respectively. Furthermore, the local application of 8-OH-DPAT, 1.5 microg, in the DRN completely inhibited the firing rate of 5-HT neurons in normal and sham rats, while having no effect on firing rate in the lesioned rats. Altogether, these results indicate that lesion of the nigrostriatal pathway leads to hyperactivity of DRN and MRN 5-HT neurons, suggesting the implication of the DRN and MRN in the pathophysiology of Parkinson's disease, and the decreased response of these 5-HT neurons to 5-HT(1A) receptor stimulation, reflecting 5-HT(1A) receptor dysfunction in 6-OHDA-lesioned rats. FAU - Wang, S AU - Wang S AD - Department of Physiology and Pathophysiology, School of Medicine, Xi'an Jiaotong University, Xi'an 710061, Shaanxi, China. FAU - Zhang, Q J AU - Zhang QJ FAU - Liu, J AU - Liu J FAU - Wu, Z H AU - Wu ZH FAU - Wang, T AU - Wang T FAU - Gui, Z H AU - Gui ZH FAU - Chen, L AU - Chen L FAU - Wang, Y AU - Wang Y LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090103 PL - United States TA - Neuroscience JT - Neuroscience JID - 7605074 RN - 0 (Piperazines) RN - 0 (Pyridines) RN - 0 (Serotonin Antagonists) RN - 0 (Serotonin Receptor Agonists) RN - 112692-38-3 (Receptor, Serotonin, 5-HT1A) RN - 333DO1RDJY (Serotonin) RN - 71IH826FEG (N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide) RN - 78950-78-4 (8-Hydroxy-2-(di-n-propylamino)tetralin) SB - IM MH - 8-Hydroxy-2-(di-n-propylamino)tetralin/pharmacology MH - Action Potentials/drug effects/*physiology MH - Analysis of Variance MH - Animals MH - Corpus Striatum/physiology MH - Dose-Response Relationship, Drug MH - Functional Laterality/physiology MH - Male MH - Neural Inhibition/drug effects MH - Neural Pathways/drug effects/*injuries/physiology MH - Neurons/drug effects/*physiology MH - Piperazines/pharmacology MH - Pyridines/pharmacology MH - Raphe Nuclei/*cytology MH - Rats MH - Rats, Sprague-Dawley MH - Receptor, Serotonin, 5-HT1A/*physiology MH - Serotonin/*metabolism MH - Serotonin Antagonists/pharmacology MH - Serotonin Receptor Agonists/pharmacology MH - Statistics, Nonparametric MH - Substantia Nigra/physiology EDAT- 2009/01/29 09:00 MHDA- 2009/06/18 09:00 CRDT- 2009/01/29 09:00 PHST- 2008/08/20 00:00 [received] PHST- 2008/12/28 00:00 [revised] PHST- 2008/12/30 00:00 [accepted] PHST- 2009/01/29 09:00 [entrez] PHST- 2009/01/29 09:00 [pubmed] PHST- 2009/06/18 09:00 [medline] AID - S0306-4522(08)01871-X [pii] AID - 10.1016/j.neuroscience.2008.12.051 [doi] PST - ppublish SO - Neuroscience. 2009 Mar 17;159(2):850-61. doi: 10.1016/j.neuroscience.2008.12.051. Epub 2009 Jan 3.